Location History:
- Paris, FR (2022)
- Le Blanc Mesnil, FR (2020 - 2023)
Company Filing History:
3 out of 154 
3 out of 1,743 
3 out of 5,081 
Years Active: 2020-2023
Title: Christel Goudot: Innovator in Engineered Immune Cells
Introduction
Christel Goudot is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology, particularly in the development of engineered immune cells. With a total of 3 patents, her work focuses on advancing cancer treatment through innovative methodologies.
Latest Patents
One of her latest patents involves the creation of immune cells defective for SUV39H1. This invention relates to an engineered immune cell that is specifically designed to inhibit the expression and/or activity of Suv39h1. The engineered immune cell also includes a genetically engineered antigen receptor that binds to a target antigen. This invention is particularly relevant for adoptive therapy, especially in the treatment of cancer.
Career Highlights
Christel Goudot has worked with esteemed institutions such as Institut Curie and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in the field of cancer immunotherapy, showcasing her dedication to improving patient outcomes through innovative solutions.
Collaborations
Throughout her career, Christel has collaborated with notable colleagues, including Sebastian Amigorena and Eliane Piaggio. These partnerships have further enriched her research and contributed to the advancement of her inventions.
Conclusion
Christel Goudot's work in engineered immune cells represents a significant advancement in cancer treatment. Her innovative patents and collaborations highlight her commitment to improving healthcare through scientific research.